Markets:

Overview

News

Currencies

International

Treasuries

iShares Global Healthcare ETF (NY:IXJ)

106.89 +2.98 (+2.87%)

Streaming Delayed Price Updated: 1:27 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Global Healthcare ETF

< Previous 1 2 Next >

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Trump Overrode RFK Jr. And Makary To Remove FDA Biologics Chief Amid Sarepta Drug Controversy: Report ↗

July 31, 2025

The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially splitting it into separate offices for vaccines and therapeutics.

Via Stocktwits

Topics Death ETFs Government

RFK Jr. Said To Be Planning Another Health Panel Shakeup — This Time Targeting Preventive Care ↗

July 29, 2025

Via Stocktwits

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at...

Via MarketMinute

Topics ETFs Economy

Global Healthcare ETFs ↗

April 20, 2021

Trevor Cummings discusses Global Healthcare ETFs and outlook for the rest of 2021 with Deborah Fuhr.

Via Talk Markets

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens ↗

January 31, 2025

The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025.

Via Stocktwits

J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient ↗

January 22, 2025

During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually.

Via Stocktwits

Topics Earnings

World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements ↗

January 22, 2025

Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.

Via Benzinga

Topics Government

Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings

August 09, 2024

Novo Nordisk fell over 8% after its earnings release but recovered nearly all of those losses the next day. It needs to increase supplies of semaglutide.

Via MarketBeat

Topics ETFs

Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy ↗

June 22, 2024

You don't need to be a stock market expert to earn above-average returns.

Via The Motley Fool

Top ETFs for Every Sector ↗

February 22, 2024

Top ETFs for all 11 S&P 500 sectors.

Via The Motley Fool

Topics ETFs Stocks

Market Mayhem: 3 ETFs to Anchor Your Investments in 2024 ↗

January 10, 2024

The top ETFs for 2024 are thematic or sector-specific tickers with upside, presenting market-beating opportunities.

Via InvestorPlace

Topics ETFs

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

3 Healthcare Technology Stocks to Improve Lives in 2024 ↗

December 25, 2023

Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.

Via InvestorPlace

Worried About a Recession? Stash Your Cash in These 2 ETFs. ↗

May 25, 2023

Rather than holding your cash, consider investing it in these stable ETFs.

Via The Motley Fool

US Supports Delay On COVID Patent Waiver Extension Decision ↗

December 06, 2022

Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health...

Via Benzinga

7 Profitable Places to Hide Your Money During a Bear Market ↗

May 13, 2022

With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification.

Via InvestorPlace

Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19 ↗

December 07, 2021

The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or severe cases. The treatment uses...

Via Benzinga

New Drug Applications Pile Up With FDA As Pandemic Still Sore Spot For Delayed Inspections ↗

November 23, 2021

The FDA continues to face a backlog of drug manufacturing facility inspections. A total of 52 new drug (but no biologics) applications remain delayed due to the backlog...

Via Benzinga

UK Rolls Out COVID-19 Antibody Tests For All: What You Need To Know ↗

August 23, 2021

On Sunday, the U.K. government rolled out a new nationwide antibody surveillance program, in which anyone over 18 years can opt-in when having a PCR test from Tuesday....

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.